The department has reached a remarkable activity level despite being quite new. The staff amounts to about thirty members including physicians, engineers, nurses and doctors, and can treat as many as 15 patients per day with different radiopharmaceutical provisions. Karl100 helps the staff focusing on FDG and NaF mainly, while some FBB-related tests will be carried out independently.
“This is such a gratifying result we want to share with our partner Applied Chemical and Instrument Co., Ltd for its support” says Alessandro Trerè, Sales Product Specialist for Nuclear Medicine.